25 results on '"Stuessi, Georg"'
Search Results
2. Genetic and phenotypic attributes of splenic marginal zone lymphoma
3. Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland
4. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma
5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
6. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
7. Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma
8. Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with AML and high risk MDS
9. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)
10. Multilayer Profiling of MRD in Patients with Relapsed/Refractory CLL Treated with Venetoclax-Based Regimens in a Real-World Setting
11. Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
12. Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
13. Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance
14. Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial
15. CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway
16. Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway
17. A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression
18. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
19. Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma
20. Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013
21. International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia
22. Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland Between 2001 and 2012
23. Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2-Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14
24. Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy
25. Analysis of the Early Clonal Dynamics in Ibrutinib-Treated Chronic Lymphocytic Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.